Plasmalemma vesicle‑associated protein: A crucial component of vascular homeostasis (Review)

Guo,Ling; Zhang,Hongyan; Hou,Yinglong; Wei,Tianshu; Liu,Ju

doi:10.3892/etm.2016.3557

Plasmalemma vesicle‑associated protein: A crucial component of vascular homeostasis (Review)

Authors:
- Ling Guo
- Hongyan Zhang
- Yinglong Hou
- Tianshu Wei
- Ju Liu
View Affiliations

Affiliations: Laboratory of Microvascular Medicine, Medical Research Center, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China, Department of Cardiovascular Medicine, Xintai City People's Hospital Affiliated to Taishan Medical University, Xintai, Shandong 271200, P.R. China, Department of Cardiology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China, Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria 3010, Australia
Published online on: July 27, 2016 https://doi.org/10.3892/etm.2016.3557
Pages: 1639-1644
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endothelial subcellular structures, including caveolae, fenestrae and transendothelial channels, are crucial for regulating microvascular function. Plasmalemma vesicle‑associated protein (PLVAP) is an endothelial cell‑specific protein that forms the stomatal and fenestral diaphragms of blood vessels and regulates basal permeability, leukocyte migration and angiogenesis. Loss of PLVAP in mice leads to premature mortality due to disrupted homeostasis. Evidence from previous studies suggested that PLVAP is involved in cancer, traumatic spinal cord injury, acute ischemic brain disease, transplant glomerulopathy, Norrie disease and diabetic retinopathy. Specifically, PLVAP expression has been demonstrated to be upregulated in these diseases, accompanied by pro‑angiogenic or pro‑inflammatory responses. Therefore, PLVAP is considered a novel therapeutic target, in addition to an endothelial cell marker. The present review summarizes the structure and functions of PLVAP, and its roles in pathophysiological processes.

View Figures

View References

1	Aird WC: Phenotypic heterogeneity of the endothelium: I. Structure, function and mechanisms. Circ Res. 100:158–173. 2007. View Article : Google Scholar : PubMed/NCBI
2	Aird WC: Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 100:174–190. 2007. View Article : Google Scholar : PubMed/NCBI
3	Tse D and Stan RV: Morphological heterogeneity of endothelium. Semin Thromb Hemost. 36:236–245. 2010. View Article : Google Scholar : PubMed/NCBI
4	Stan RV: Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis. J Cell Mol Med. 11:621–643. 2007. View Article : Google Scholar : PubMed/NCBI
5	Stan RV, Ghitescu L, Jacobson BS and Palade GE: Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol. 145:1189–1198. 1999. View Article : Google Scholar : PubMed/NCBI
6	Stan RV: Structure of caveolae. Biochim Biophys Acta. 1746:334–348. 2005. View Article : Google Scholar : PubMed/NCBI
7	Bearer EL and Orci L: Endothelial fenestral diaphragms: A quick-freeze, deep-etch study. J Cell Biol. 100:418–428. 1985. View Article : Google Scholar : PubMed/NCBI
8	Simionescu M, Simionescu N, Silbert JE and Palade GE: Differentiated microdomains on the luminal surface of the capillary endothelium. II. Partial characterization of their anionic sites. J Cell Biol. 90:614–621. 1981. View Article : Google Scholar : PubMed/NCBI
9	Rostgaard J and Qvortrup K: Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res. 53:1–13. 1997. View Article : Google Scholar : PubMed/NCBI
10	Stan RV, Tse D, Deharvengt SJ, Smits NC, Xu Y, Luciano MR, McGarry CL, Buitendijk M, Nemani KV, Elgueta R, et al: The diaphragms of fenestrated endothelia: Gatekeepers of vascular permeability and blood composition. Dev Cell. 23:1203–1218. 2012. View Article : Google Scholar : PubMed/NCBI
11	Milici AJ, L'Hernault N and Palade GE: Surface densities of diaphragmed fenestrae and transendothelial channels in different murine capillary beds. Circ Res. 56:709–717. 1985. View Article : Google Scholar : PubMed/NCBI
12	Hallmann R, Mayer DN, Berg EL, Broermann R and Butcher EC: Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev Dyn. 202:325–332. 1995. View Article : Google Scholar : PubMed/NCBI
13	Niemela H, Elima K, Henttinen T, Irjala H, Salmi M and Jalkanen S: Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood. 106:3405–3409. 2005. View Article : Google Scholar : PubMed/NCBI
14	Stan RV, Tkachenko E and Niesman IR: PV1 is a key structural component for the formation of the stomatal and fenestral diaphragms. Mol Biol Cell. 15:3615–3630. 2004. View Article : Google Scholar : PubMed/NCBI
15	Ioannidou S, Deinhardt K, Miotla J, Bradley J, Cheung E, Samuelsson S, Ng YS and Shima DT: An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis. Proc Natl Acad Sci USA. 103:16770–16775. 2006. View Article : Google Scholar : PubMed/NCBI
16	Madden SL, Cook BP, Nacht M, Weber WD, Callahan MR, Jiang Y, Dufault MR, Zhang X, Zhang W, WalterYohrling J, et al: Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol. 165:601–608. 2004. View Article : Google Scholar : PubMed/NCBI
17	CarsonWalter EB, Hampton J, Shue E, Geynisman DM, Pillai PK, Sathanoori R, Madden SL, Hamilton RL and Walter KA: Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin Cancer Res. 11:7643–7650. 2005. View Article : Google Scholar : PubMed/NCBI
18	Liu Y, CarsonWalter EB, Cooper A, Winans BN, Johnson MD and Walter KA: Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol. 99:13–24. 2010. View Article : Google Scholar : PubMed/NCBI
19	Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M and Jalkanen S: The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood. 114:478–484. 2009. View Article : Google Scholar : PubMed/NCBI
20	Minshall RD and Malik AB: Transport across the endothelium: Regulation of endothelial permeability. Handb Exp Pharmacol. 107–144. 2006. View Article : Google Scholar : PubMed/NCBI
21	Schafer NF, Luhmann UF, Feil S and Berger W: Differential gene expression in Ndph-knockout mice in retinal development. Invest Ophthalmol Vis Sci. 50:906–916. 2009. View Article : Google Scholar : PubMed/NCBI
22	Klaassen I, Hughes JM, Vogels IM, Schalkwijk CG, Van Noorden CJ and Schlingemann RO: Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Exp Eye Res. 89:4–15. 2009. View Article : Google Scholar : PubMed/NCBI
23	WisniewskaKruk J, Hoeben KA, Vogels IM, Gaillard PJ, Van Noorden CJ, Schlingemann RO and Klaassen I: A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes. Exp Eye Res. 96:181–190. 2012. View Article : Google Scholar : PubMed/NCBI
24	WisniewskaKruk J, Klaassen I, Vogels IM, Magno AL, Lai CM, Van Noorden CJ, Schlingemann RO and Rakoczy EP: Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Exp Eye Res. 122:123–131. 2014. View Article : Google Scholar : PubMed/NCBI
25	Mozer AB, Whittemore SR and Benton RL: Spinal microvascular expression of PV-1 is associated with inflammation, perivascular astrocyte loss, and diminished EC glucose transport potential in acute SCI. Curr Neurovasc Res. 7:238–250. 2010. View Article : Google Scholar : PubMed/NCBI
26	Yamamoto I, Horita S, Takahashi T, Tanabe K, Fuchinoue S, Teraoka S, Hattori M and Yamaguchi Y: Glomerular expression of plasmalemmal vesicle-associated protein-1 in patients with transplant glomerulopathy. Am J Transplant. 7:1954–1960. 2007. View Article : Google Scholar : PubMed/NCBI
27	Wang YH, Cheng TY, Chen TY, Chang KM, Chuang VP and Kao KJ: Plasmalemmal vesicle associated protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma. BMC Cancer. 14:8152014. View Article : Google Scholar : PubMed/NCBI
28	Stan RV, Kubitza M and Palade GE: PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci USA. 96:13203–13207. 1999. View Article : Google Scholar : PubMed/NCBI
29	Hnasko R, McFarland M and Ben-Jonathan N: Distribution and characterization of plasmalemma vesicle protein-1 in rat endocrine glands. J Endocrinol. 175:649–661. 2002. View Article : Google Scholar : PubMed/NCBI
30	Stan RV, Arden KC and Palade GE: cDNA and protein sequence, genomic organization and analysis of cis regulatory elements of mouse and human PLVAP genes. Genomics. 72:304–313. 2001. View Article : Google Scholar : PubMed/NCBI
31	Stan RV: Multiple PV1 dimers reside in the same stomatal or fenestral diaphragm. Am J Physiol Heart Circ Physiol. 286:H1347–H1353. 2004. View Article : Google Scholar : PubMed/NCBI
32	Deharvengt SJ, Tse D, Sideleva O, McGarry C, Gunn JR, Longnecker DS, Carriere C and Stan RV: PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts. J Cell Mol Med. 16:2690–2700. 2012. View Article : Google Scholar : PubMed/NCBI
33	Strickland LA, Jubb AM, Hongo JA, Zhong F, Burwick J, Fu L, Frantz GD and Koeppen H: Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF). J Pathol. 206:466–475. 2005. View Article : Google Scholar : PubMed/NCBI
34	Hofman P, Blaauwgeers HG, Vrensen GF and Schlingemann RO: Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys. Ophthalmic Res. 33:156–162. 2001. View Article : Google Scholar : PubMed/NCBI
35	Hnasko R, Frank PG, BenJonathan N and Lisanti MP: PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice. Cell Cycle. 5:2012–2020. 2006. View Article : Google Scholar : PubMed/NCBI
36	Herrnberger L, Seitz R, Kuespert S, Bösl MR, Fuchshofer R and Tamm ER: Lack of endothelial diaphragms in fenestrae and caveolae of mutant Plvap-deficient mice. Histochem Cell Biol. 138:709–724. 2012. View Article : Google Scholar : PubMed/NCBI
37	Hisatsune H, Matsumura K, Ogawa M, Uemura A, Kondo N, Yamashita JK, Katsuta H and Nishikawa S, Chiba T and Nishikawa S: High level of endothelial cell-specific gene expression by a combination of the 5′ flanking region and the 5′ half of the first intron of the VE-cadherin gene. Blood. 105:4657–4663. 2005. View Article : Google Scholar : PubMed/NCBI
38	Williamson JR and Grisham JW: Electron microscopy of leukocytic margination and emigration in acute inflammation in dog pancreas. Am J Pathol. 39:239–256. 1961.PubMed/NCBI
39	Girard JP, Moussion C and Förster R: HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol. 12:762–773. 2012. View Article : Google Scholar : PubMed/NCBI
40	Germain RN, Robey EA and Cahalan MD: A decade of imaging cellular motility and interaction dynamics in the immune system. Science. 336:1676–1681. 2012. View Article : Google Scholar : PubMed/NCBI
41	Rantakari P, Auvinen K, Jäppinen N, Kapraali M, Valtonen J, Karikoski M, Gerke H, Iftakhar-E-Khuda I, Keuschnigg J, Umemoto E, et al: The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes. Nat Immunol. 16:386–396. 2015. View Article : Google Scholar : PubMed/NCBI
42	Tichauer KM, Deharvengt SJ, Samkoe KS, Gunn JR, Bosenberg MW, Turk MJ, Hasan T, Stan RV and Pogue BW: Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging. Mol Imaging Biol. 16:372–382. 2014. View Article : Google Scholar : PubMed/NCBI
43	Shue EH, CarsonWalter EB, Liu Y, Winans BN, Ali ZS, Chen J and Walter KA: Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models. BMC Neurosci. 9:292008. View Article : Google Scholar : PubMed/NCBI
44	Whetstone WD, Hsu JY, Eisenberg M, Werb Z and Noble-Haeusslein LJ: Blood-spinal cord barrier after spinal cord injury: Relation to revascularization and wound healing. J Neurosci Res. 74:227–239. 2003. View Article : Google Scholar : PubMed/NCBI
45	Benton RL, Maddie MA, Minnillo DR, Hagg T and Whittemore SR: Griffonia simplicifolia isolectin B4 identifies a specific subpopulation of angiogenic blood vessels following contusive spinal cord injury in the adult mouse. J Comp Neurol. 507:1031–1052. 2008. View Article : Google Scholar : PubMed/NCBI
46	Casella GT, Bunge MB and Wood PM: Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cord. Exp Neurol. 202:8–20. 2006. View Article : Google Scholar : PubMed/NCBI
47	Ichimura K, Stan RV, Kurihara H and Sakai T: Glomerular endothelial cells form diaphragms during development and pathologic conditions. J Am Soc Nephrol. 19:1463–1471. 2008. View Article : Google Scholar : PubMed/NCBI
48	Joosten SA, Sijpkens YW, van Kooten C and Paul LC: Chronic renal allograft rejection: Pathophysiologic considerations. Kidney Int. 68:1–13. 2005. View Article : Google Scholar : PubMed/NCBI
49	Shastry BS, Hejtmancik JF and Trese MT: Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum Mutat. 9:396–401. 1997. View Article : Google Scholar : PubMed/NCBI
50	Black GC, Perveen R, Bonshek R, Cahill M, ClaytonSmith J, Lloyd IC and McLeod D: Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: A role for norrin in retinal angiogenesis. Hum Mol Genet. 8:2031–2035. 1999. View Article : Google Scholar : PubMed/NCBI
51	Chen ZY, Battinelli EM, Fielder A, Bundey S, Sims K, Breakefield XO and Craig IW: A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet. 5:180–183. 1993. View Article : Google Scholar : PubMed/NCBI
52	Luhmann UF, Lin J, Acar N, Lammel S, Feil S, Grimm C, Seeliger MW, Hammes HP and Berger W: Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci. 46:3372–3382. 2005. View Article : Google Scholar : PubMed/NCBI
53	Hofman P, Blaauwgeers HG, Tolentino MJ, Adamis AP, Nunes Cardozo BJ, Vrensen GF and Schlingemann RO: VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A. Curr Eye Res. 21:637–645. 2000. View Article : Google Scholar : PubMed/NCBI